Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 13
2017 8
2018 3
2019 7
2020 6
2021 5
2022 6
2023 4
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantation.
Shimomura Y, Komukai S, Kitamura T, Tachibana T, Kurosawa S, Itonaga H, Tsukamoto S, Doki N, Katayama Y, Ito A, Sawa M, Ueda Y, Nakamae H, Nawa Y, Tanaka M, Arai Y, Ota S, Kataoka K, Nishida T, Kanda J, Fukuda T, Atsuta Y, Ishiyama K. Shimomura Y, et al. Among authors: kurosawa s. Br J Haematol. 2024 Feb;204(2):612-622. doi: 10.1111/bjh.19139. Epub 2023 Oct 19. Br J Haematol. 2024. PMID: 37857379
Erythrocytosis after allogeneic hematopoietic stem cell transplantation.
Hino Y, Doki N, Kurosawa S, Yamamoto K, Sakaguchi M, Harada K, Ikegawa S, Shingai N, Hattori K, Senoo Y, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Hino Y, et al. Among authors: kurosawa s. Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12918. Epub 2017 Feb 28. Clin Transplant. 2017. PMID: 28247439 No abstract available.
The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy.
Kurosawa S, Sekiya N, Doki N, Yaguchi T, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Kurosawa S, et al. Int J Infect Dis. 2019 Dec;89:154-162. doi: 10.1016/j.ijid.2019.10.003. Epub 2019 Oct 9. Int J Infect Dis. 2019. PMID: 31605809 Free article. Review.
Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature.
Shirane S, Najima Y, Fukushima K, Sekiya N, Funata N, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Kurosawa S, Yoshifuji K, Uchida T, Inamoto K, Shingai N, Toya T, Igarashi A, Shimizu H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K, Horiguchi SI, Hishima T, Doki N. Shirane S, et al. Among authors: kurosawa s. J Infect Chemother. 2022 Dec;28(12):1658-1662. doi: 10.1016/j.jiac.2022.08.003. Epub 2022 Aug 10. J Infect Chemother. 2022. PMID: 35963603 Review.
Toxic encephalopathy after exposure to azacitidine.
Watanabe K, Doki N, Miura Y, Hagino T, Kurosawa S, Hino Y, Shingai N, Yoshioka K, Ishida S, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Watanabe K, et al. Among authors: kurosawa s. Leuk Lymphoma. 2015 May;56(5):1538-9. doi: 10.3109/10428194.2014.964701. Epub 2014 Nov 5. Leuk Lymphoma. 2015. PMID: 25224457 No abstract available.
[Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis].
Kurosawa S, Doki N, Kaito S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Ikegawa S, Yosioka K, Watanabe D, Senoo Y, Watakabe K, Hagino T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Miyawaki S, Sakamaki H, Ohashi K. Kurosawa S, et al. Rinsho Ketsueki. 2016 Apr;57(4):461-6. doi: 10.11406/rinketsu.57.461. Rinsho Ketsueki. 2016. PMID: 27169451 Review. Japanese.
Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched Analysis.
Kurosawa S, Shimomura Y, Itonaga H, Najima Y, Kobayashi T, Ozawa Y, Kanda Y, Kako S, Kawakita T, Matsuoka KI, Maruyama Y, Ota S, Nakazawa H, Imada K, Kimura T, Kanda J, Fukuda T, Atsuta Y, Ishiyama K. Kurosawa S, et al. Transplant Cell Ther. 2022 Jun;28(6):323.e1-323.e9. doi: 10.1016/j.jtct.2022.03.011. Epub 2022 Mar 13. Transplant Cell Ther. 2022. PMID: 35296446 Free article.
Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis.
Kurosawa S, Shimomura Y, Itonaga H, Najima Y, Kobayashi T, Ozawa Y, Kanda Y, Kako S, Kawakita T, Matsuoka KI, Maruyama Y, Ota S, Nakazawa H, Imada K, Kanda J, Fukuda T, Atsuta Y, Aoki J. Kurosawa S, et al. Bone Marrow Transplant. 2021 Dec;56(12):3008-3015. doi: 10.1038/s41409-021-01447-y. Epub 2021 Sep 7. Bone Marrow Transplant. 2021. PMID: 34489555
53 results